Showing results (1671-1680 of 1,768) with videos related to
Sort By:
Pageof 177
Clinical Pharmacology and Therapeutics|January 23, 2026
Emulating Comparative Oncology Trials With Real-World Evidence Studies (ENCORE): Process Development and Methodological Considerations for Oncology Real-World DataJanick Weberpals, Sebastian Schneeweiss, Kenneth L Kehl, et al.Journal of Medicinal Chemistry|February 3, 2009
Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonistsJ Robert Merritt, Jinqi Liu, Elizabeth Quadros, et al.British Journal of Pharmacology|October 22, 2011
Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorChris J van Koppen, Marcel E de Gooyer, Willem-Jan Karstens, et al.Breast Cancer Research and Treatment|September 12, 2014
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancerGayle S Jameson, Emanuel F Petricoin, Jasgit Sachdev, et al.Genome Biology|May 30, 2020
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing dataLiqing Tian, Yongjin Li, Michael N Edmonson, et al.Therapeutic Advances in Medical Oncology|October 10, 2024
Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across CanadaJ Robert Beecroft, Savtaj Brar, Xiaolan Feng, et al.Environmental Monitoring and Assessment|September 19, 2022
A novel method for identifying coded tags recorded on aquatic acoustic monitoring systemsChristopher D Lowe, Nicolas J C Tregenza, Claudia J Allen, et al.Lancet (London, England)|November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.Science Advances|June 22, 2022
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomasDeanna M Tiek, Beril Erdogdu, Roham Razaghi, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2019
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French ConsiliumL Guglielmetti, J Jaffré, C Bernard, et al.Pageof 177